Skip to main content
. 2024 Jun 22;76:103762. doi: 10.1016/j.breast.2024.103762

Table 2.

Treatments for Chinese male breast cancer patients by period of diagnosis.

Variables Period of diagnosis
Totala
P value of test for trend over time
Dec. 2009 or earlier (N = 128)
N (%)
Jan. 2010 to Dec. 2019 (N = 722)
N (%)
Jan. 2020 or later (N = 258)
N (%)
(N = 1119)
N (%)
Breast surgery 0.041
 Mastectomy 119(93.0) 641(88.8) 230(89.1) 1000(89.1)
 Partial mastectomy 7(5.5) 31(4.3) 5(1.9) 43(3.8)
 No 1(0.8) 34(4.7) 17(6.6) 53(4.7)
 Unknown 1(0.8) 16(2.2) 6(2.3) 23(2.1)
Axillary surgery <0.001
 SLNB 10(7.8) 154(21.3) 100(38.8) 265(23.7)
 ALND 112(87.5) 459(63.6) 125(48.4) 705(63.0)
 No 4(3.1) 81(11.2) 25(9.7) 110(9.8)
 Unknown 2(1.6) 28(3.9) 8(3.1) 39(3.5)
Radiotherapy 0.520
 Yes 25(19.5) 178(24.7) 60(23.3) 264(23.6)
 No 60(46.9) 424(58.7) 174(67.4) 658(58.8)
 Unknown 43(33.6) 120(16.6) 24(9.3) 197(17.6)
Chemotherapy 0.002
 Yes 71(55.5) 376(52.1) 136(52.7) 588(52.5)
 No 17(13.3) 234(32.4) 89(34.5) 339(30.3)
 Unknown 40(31.3) 112(15.5) 33(12.8) 192(17.2)
Endocrine therapy (HR positive cases) 0.165
 Yes 89(78.1) 458(72.2) 168(71.5) 716(72.3)
 No 9(7.9) 92(14.5) 32(13.6) 133(13.4)
 Unknown 16(14.0) 84(13.2) 35(14.9) 142(14.3)
 Total 114(100) 634(100) 235(100) 991(100)
Anti-HER-2 therapy (HER-2 positive cases) 0.010
 Yes 1(14.3) 33(40.2) 32(72.7) 63(47.0)
 No 1(14.3) 30(36.6) 7(15.9) 40(29.9)
 Unknown 5(71.4) 19(23.2) 5(11.4) 31(23.1)
 Total 7(100) 82(100) 44(100) 134(100)

Abbreviations: SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; HR, hormone receptor; HER-2, human epidermal growth factor receptor 2.

a

The exact year of diagnosis of 11 cases were unknown. These cases were thus recorded in the column Total only.